A. Suzuki

发表

8-1A, a human monoclonal antibody that reacts with intact human chorionic gonadotropin.

I. Ishida, D. Aoki, N. Susumu, 2006, Placenta.

Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer

D. Aoki, N. Susumu, S. Nozawa, 2005, International Journal of Gynecologic Cancer.

Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen

I. Ishida, D. Aoki, N. Susumu, 2007, International Journal of Gynecologic Cancer.

HMMC-1

M. Fukuda, I. Ishida, D. Aoki, 2004, Clinical Cancer Research.

HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.

I. Ishida, D. Aoki, N. Susumu, 2004, Gynecologic oncology.

HMMC‐1, a human monoclonal antibody to fucosylated core 1 O‐glycan, suppresses growth of uterine endometrial cancer cells

D. Aoki, E. Tominaga, Kyoko Tanaka, 2013, Cancer science.

The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.

Y. Ohnishi, M. Hatae, H. Tsuda, 2010, European journal of obstetrics, gynecology, and reproductive biology.

Subcellular Localization of Galactosyltransferase Associated with Tumors in Endometrial and Ovarian Cancer Cells

D. Aoki, N. Susumu, S. Nozawa, 2003 .

Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

Proteomic characterization of ovarian cancers identifying annexin‐A4, phosphoserine aminotransferase, cellular retinoic acid‐binding protein 2, and serpin B5 as histology‐specific biomarkers

Yusuke Nakamura, Takashi Shimada, Daisuke Aoki, 2012, Cancer science.

Anisakiasis mimics cancer recurrence: two cases of extragastrointestinal anisakiasis suspected to be recurrence of gynecological cancer on PET-CT and molecular biological investigation

Atsushi Suzuki, Hiromu Sugiyama, Daisuke Aoki, 2016, BMC Medical Imaging.

Diagnostic clinical application of two‐color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid‐based thin‐layer cytologic preparations of endometrial cancers

H. Tsuda, D. Aoki, N. Susumu, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers

J. Inazawa, H. Tsuda, D. Aoki, 2004, International Journal of Gynecologic Cancer.

A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

D. Aoki, N. Susumu, S. Nozawa, 2004, Gynecologic oncology.

Anti-vascular endothelial growth factor receptor 1 antibody as an antagonist for cancer therapy through targeting cancer cells and tumor angiogenesis

I. Ishida, D. Aoki, Yan Wu, 2006 .

Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.

T. Irimura, D. Aoki, N. Susumu, 2006, Oncology research.

Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma

D. Aoki, N. Susumu, S. Nozawa, 2008, Human Cell.

Lymph Node Metastasis in Grossly Apparent Stages I and II Epithelial Ovarian Cancer

H. Tsuda, D. Aoki, E. Tominaga, 2009, International Journal of Gynecologic Cancer.

Effects of third-line chemotherapy for women with recurrent ovarian cancer who received platinum/taxane regimens as first-line chemotherapy.

D. Aoki, E. Tominaga, N. Susumu, 2010, European Journal of Gynaecological Oncology.

Can ABCF2 protein expression predict the prognosis of uterine cancer?

Y. Miyagi, D. Aoki, A. Hirasawa, 2008, British Journal of Cancer.

A novel method for analyzing formalin-fixed paraffin embedded (FFPE) tissue sections by mass spectrometry imaging.

Yusuke Nakamura, Takashi Shimada, Daisuke Aoki, 2007 .

A Case of Metastatic Uterine Tumor Originating from Small-Cell Lung Cancer (SCLC) Mimicking Uterine Sarcoma

J. Shibahara, K. Nagahama, Yoichi Kobayashi, 2021, Case reports in obstetrics and gynecology.

Specific expression of hepatocyte nuclear factor‐1β in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis

M. Sakamoto, D. Aoki, N. Susumu, 2007, Cancer science.

Proteomic characterization of ovarian cancers identifying annexin‐A4, phosphoserine aminotransferase, cellular retinoic acid‐binding protein 2, and serpin B5 as histology‐specific biomarkers

Yusuke Nakamura, Taka-Aki Sato, T. Shimada, 2012, Cancer science.